Metraipolis › archive › dc_94c2e2cf0863

Pharmacological Inhibition of SP1 Reverses Cancer Stemness and Enhances Sorafenib Efficacy in Hepatocellular Carcinoma — Europe PMC PMID:42274554

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42274554
DOI
10.3390/cells15110961
License (as archived)
solo-consultazione
Archived
2026-11-01T10:04:19.779Z
SHA-256 of the archived text
fba4db2fdaba9321cd1a85c8f976efbe103f13d6ac99f32eb4cefa614c5b3baa
Stable URL of this page
https://metraipolis.com/documento/dc_94c2e2cf0863

How to cite

Pharmacological Inhibition of SP1 Reverses Cancer Stemness and Enhances Sorafenib Efficacy in Hepatocellular Carcinoma — Europe PMC PMID:42274554 — Europe PMC (en), https://europepmc.org/article/MED/42274554 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_94c2e2cf0863 (Metraipolis archive dc_94c2e2cf0863, sha256 fba4db2fdaba9321cd1a85c8f976efbe103f13d6ac99f32eb4cefa614c5b3baa)
BibTeX
@misc{dc94c2e2cf0863,
  title = {Pharmacological Inhibition of SP1 Reverses Cancer Stemness and Enhances Sorafenib Efficacy in Hepatocellular Carcinoma — Europe PMC PMID:42274554},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42274554},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_94c2e2cf0863; sha256 fba4db2fdaba9321cd1a85c8f976efbe103f13d6ac99f32eb4cefa614c5b3baa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42274554. Agents can read the archived copy with the MCP tool read_document.